SHPH SHUTTLE PHARMACEUTICALS HOLDINGS INC Investor Conferences 8-K Filing 2024 - Investor Conference Shuttle Pharmaceuticals announced that CEO Dr. Anatoly Dritschilo will present at the ThinkEquity Conference on October 30, 2024, discussing the company's clinical trial progress and plans for its subsidiary, Shuttle Diagnostics, with a focus on glioblastoma and prostate cancer research.Get access to all SEC 8-K filings of the SHUTTLE PHARMACEUTICALS HOLDINGS INC